| TYPE0 BAV (n = 86) | TYPE1 BAV (n = 109) | TAV (n = 149) | P value |
---|---|---|---|---|
Age(yrs) | 72.90 ± 7.06 | 76.31 ± 7.17 | 77.05 ± 9.32 | 0.001 |
Sex, male(n.%) | 41 (47.67) | 55 (50.46) | 77 (51.68) | 0.839 |
BMI | 23.86 ± 2.84 | 23.05 ± 2.93 | 23.96 ± 3.75 | 0.085 |
NYHA ≥ III(n.%) | 68 (79.07) | 91 (83.49) | 122 (81.88) | 0.729 |
STS score | 4.15 ± 1.79 | 4.50 ± 1.59 | 5.14 ± 2.15 | < 0.001 |
Hypertension(n.%) | 32 (37.21) | 57 (52.29) | 111 (74.50) | < 0.001 |
Diabetes mellitus (n.%) | 18 (20.93) | 18 (16.51) | 43 (28.86) | 0.058 |
Creatine(mg/dL) | 92.52 ± 91.05 | 96.22 ± 49.26 | 119.17 ± 121.68 | 0.068 |
Peripheral vascular disease(n.%) | 6 (6.98) | 16 (14.68) | 25 (16.78) | 0.101 |
Prior cerebrovascular(n.%) accident | 6 (6.98) | 8 (7.34) | 11 (7.38) | 0.914 |
Chronic lung disease(n.%) | 45 (52.33) | 62 (56.88) | 79 (53.02) | 0.772 |
Cardiac history(n.%) | Â | Â | Â | Â |
  PCI | 6 (6.98) | 8 (7.34) | 20 (13.42) | 0.157 |
 CABG | 1 (1.16) | 1 (0.92) | 5 (3.36) | 0.383 |
 AF/Af | 21 (24.42) | 22 (20.18) | 27 (18.12) | 0.526 |
 Pre-existing pacemaker | 2 (2.33) | 4 (3.67) | 3 (2.01) | 0.696 |
Echocardiographic findings | Â | Â | Â | Â |
 Mean gradient(mmHg) | 49.06 ± 20.81 | 45.37 ± 17.15 | 44.39 ± 15.42 | 0.152 |
 Aortic valve area(mm²) | 0.62 ± 0.12 | 0.74 ± 0.43 | 0.69 ± 0.15 | 0.073 |
 LVEF(%) | 56.26 ± 15.51 | 55.83 ± 12.98 | 55.44 ± 15.71 | 0.920 |
 Maximum aortic valve Velocity(m/s) | 4.90 ± 0.81 | 4.77 ± 0.72 | 4.65 ± 0.76 | 0.528 |
 Moderate-to-severe aortic regurgitation (n.%) | 4 (4.65) | 4 (3.67) | 14 (9.40) | 0.161 |
 Moderate-to-se vere mitral regurgitation | 2 (2.33) | 2 (1.83) | 9( 6.04) | 0.207 |
Pre-CT data | Â | Â | Â | Â |
 Annulus |  |  |  |  |
 Area(mm²) | 467 (419–548) | 496(431–567) | 441(377–490) | 0.475 |
 Perimeter(mm) | 80.30 ± 7.01 | 81.98 ± 8.35 | 80.61 ± 7.67 | 0.336 |
 RCA height(mm) | 15.88 ± 3.61 | 14.97 ± 3.73 | 14.84 ± 3.07 | 0.584 |
 LM height(mm) | 17.35 ± 3.59 | 15.44 ± 3.20 | 15.92 ± 3.46 | 0.115 |
 Total leaflet CV(mm³) | 511 (287.73-885.53) | 622.50 (359.70-915.80) | 417 (217–714.00) | < 0.001 |
 Total LVOT CV(mm³) | 0 (0-34.28) | 0 (0-33.05) | 0 (0-28.93) | 0.547 |
 Excess leaflet calcification(n,%) | 45 (52.33) | 68 (62.39) | 57 (38.26) |  |
 Moderate to severe LVOT calcification(n,%) | 27 (31.40) | 30 (27.52) | 41 (27.52) | 0.878 |